Pharvaris N.V. (PHVS)

Pharvaris N.V. in the Healthcare sector is trading at $30.02 with a market capitalization of $2.6B. Wall Street consensus targets $57.13 (14 analysts), implying a +90.3% move over the next 12 months. The stock is currently 31% below its 52-week high of $43.25, remaining 2.1% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the safe zone. Risk note: RSI 24 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.